News

CTI will be responsible for marketing, sales, and development of the drug in the US, while the drug will continue to be sold outside the US by Bayer

The agreement grants Gilead worldwide commercialization rights to P-680 for the treatment of diseases including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and non-CF bronchiectasis. In addition,

Millemmium says the trial, named Evolution, will combine Velcade with lenalidomide/ dexamethasone and also explore the incremental benefit of cyclophosphamide, an alkylating agent, which in previous studies has

The study achieved statistical significance on the primary endpoint. Results across the 12 weeks of treatment showed both statistically significant and clinically relevant outcomes for patients with breakthrough

The FDA indicated that it will provide a revised timeline to Endo and Vernalis, and the companies will make an announcement when appropriate. Until the companies receive further

“Therapies currently used to treat cutaneous T-cell lymphoma fail to produce durable remissions in the majority of patients with advanced disease,” said Pablo Cagnoni, chief medical officer of

Administered via deep muscular injection, Bicillin C-R is indicated for the treatment of pediatric and adult infections caused by penicillin-G-susceptible bacteria, including moderately severe to severe upper-respiratory tract

The trial combines nimotuzumab with radiation for the treatment of diffuse intrinsic pontine glioma (DIPG), an inoperable form of brain cancer. The trial is being conducted by an

Pacira says DepoDur is the only extended-release opioid that is approved by the FDA for epidural use. A single injection of DepoDur into the lumbar epidural space may